These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 18436394)

  • 1. The role of human drug self-administration procedures in the development of medications.
    Comer SD; Ashworth JB; Foltin RW; Johanson CE; Zacny JP; Walsh SL
    Drug Alcohol Depend; 2008 Jul; 96(1-2):1-15. PubMed ID: 18436394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in translational research: drug self-administration.
    Haney M; Spealman R
    Psychopharmacology (Berl); 2008 Aug; 199(3):403-19. PubMed ID: 18283437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug self-administration methods in abuse liability evaluation.
    Henningfield JE; Cohen C; Heishman SJ
    Br J Addict; 1991 Dec; 86(12):1571-7. PubMed ID: 1786489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of human drug self-administration procedures.
    Jones JD; Comer SD
    Behav Pharmacol; 2013 Sep; 24(5-6):384-95. PubMed ID: 23839027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medications development for opioid abuse.
    Negus SS; Banks ML
    Cold Spring Harb Perspect Med; 2013 Jan; 3(1):a012104. PubMed ID: 23125072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development.
    Negus SS; Banks ML
    Pharmacol Biochem Behav; 2018 Jan; 164():32-39. PubMed ID: 28442370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.
    Haney M
    Addict Biol; 2009 Jan; 14(1):9-21. PubMed ID: 18855806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse liability studies of opioid agonist-antagonists in humans.
    Preston KL; Jasinski DR
    Drug Alcohol Depend; 1991 Jun; 28(1):49-82. PubMed ID: 1884671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder.
    Brandt L; Jones JD; Martinez S; Manubay JM; Mogali S; Ramey T; Levin FR; Comer SD
    Drug Alcohol Depend; 2020 Mar; 208():107859. PubMed ID: 31980285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine self-administration in rats: threshold procedures.
    Oleson EB; Roberts DC
    Methods Mol Biol; 2012; 829():303-19. PubMed ID: 22231823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication development for addictive disorders: the state of the science.
    Vocci FJ; Acri J; Elkashef A
    Am J Psychiatry; 2005 Aug; 162(8):1432-40. PubMed ID: 16055764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the neuropeptide S receptor antagonist RTI-118 on abuse-related facilitation of intracranial self-stimulation produced by cocaine and methylenedioxypyrovalerone (MDPV) in rats.
    Bonano JS; Runyon SP; Hassler C; Glennon RA; Stevens Negus S
    Eur J Pharmacol; 2014 Nov; 743():98-105. PubMed ID: 25220242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys.
    Negus SS; Mello NK
    Drug Alcohol Depend; 2003 May; 70(1):39-52. PubMed ID: 12681524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of agmatine on the escalation of intravenous cocaine and fentanyl self-administration in rats.
    Morgan AD; Campbell UC; Fons RD; Carroll ME
    Pharmacol Biochem Behav; 2002 Jul; 72(4):873-80. PubMed ID: 12062577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine abuse versus cocaine dependence: cocaine self-administration and pharmacodynamic response in the human laboratory.
    Walsh SL; Donny EC; Nuzzo PA; Umbricht A; Bigelow GE
    Drug Alcohol Depend; 2010 Jan; 106(1):28-37. PubMed ID: 19717246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.
    Dunn KE; Defulio A; Everly JJ; Donlin WD; Aklin WM; Nuzzo PA; Leoutsakos JM; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Exp Clin Psychopharmacol; 2013 Feb; 21(1):74-83. PubMed ID: 23205722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the abuse potential of opioids and abuse-deterrent -opioid formulations: A review of clinical study methodology.
    Setnik B; Schoedel KA; Levy-Cooperman N; Shram M; Pixton GC; Roland CL
    J Opioid Manag; 2017; 13(6):485-523. PubMed ID: 29308594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models of neurological disease (substance abuse): self-administration in monkeys.
    Platt DM; Carey G; Spealman RD
    Curr Protoc Pharmacol; 2011 Dec; Chapter 10():Unit10.5. PubMed ID: 22382996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical uses of naltrexone: a review of the evidence.
    Modesto-Lowe V; Van Kirk J
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers.
    Greenwald MK; Lundahl LH; Steinmiller CL
    Neuropsychopharmacology; 2010 Dec; 35(13):2624-37. PubMed ID: 20881947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.